Antiretroviral Therapy News

• Can Moving HIV Medicine Into Primary Care Reduce Stigma? A new call to action to reduce stigma around HIV prevention and treatment includes suggestions to integrate HIV health services more into mainstream medicine, including primary care.
  Medscape Medical News, August 19, 2022
• IAS 2022 Russia's 'War Against Evidence-Based Medicine' in Ukraine The news isn't all bad. In areas where the Ukraine government retains control, the feared outbreaks of HIV and TB didn't happen.
  Medscape Medical News, August 03, 2022
• IAS 2022 Injectable HIV Prevention Better Than Pills in Two Trials One trial confirmed the efficacy of CAB LA for transgender women who were also receiving gender-affirming hormone therapy.
  Medscape Medical News, August 02, 2022
• IAS 2022 Landmark ALLIANCE Results Offer Tenofovir Guidance Both regimens were equally effective for HIV control, but B/F/TAF produced better HBV results.
  Medscape Medical News, August 02, 2022
• Cheap Copies of GSK's HIV Prevention Drug Could Be Ready in 2026 British drugmaker GSK has struck a deal to allow low-cost generic versions of its long-acting HIV preventive medicine to be used in the developing world, including sub-Saharan Africa.
  Reuters Health Information, July 28, 2022
• IAS 2022 HIV Patient With Prolonged Remission May Open Avenue to Cure The case of a patient with HIV whose viral load dropped to undetectable levels and whose immune cells soared has captured the attention of HIV experts.
  Medscape Medical News, July 29, 2022
• Oldest Patient Yet Cured of HIV After Stem Cell Transplant The oldest patient yet has been cured of HIV after receiving a stem cell transplant for leukemia, researchers reported on Wednesday.
  Reuters Health Information, July 27, 2022
• IAS 2022 Fourth Patient Cleared of HIV After Stem Cell Transplant Is it time to start using the "C-word" (cure) instead of "remission" for these patients?
  Medscape Medical News, July 28, 2022
• Monkeypox: Large Study Highlights New Symptoms Researchers argue that monkeypox case definitions should be broadened so that cases are not misdiagnosed as other infections such as syphilis or herpes.
  Medscape Medical News, July 22, 2022
• 'Important' New Data on Second-Line HIV Treatment Regimens: The NADIA Study For second-line HIV therapy, both dolutegravir and ritonavir-boosted darunavir regimens, plus two nucleoside reverse-transcriptase inhibitors (NRTIs), maintained good viral suppression during 96 weeks follow-up in the NADIA trial.
  Reuters Health Information, June 29, 2022
• HIV Care May Have Slipped During the Pandemic An analysis by Komodo Health suggests there was less HIV screening, fewer new HIV diagnoses, and fewer new PrEP prescriptions during the pandemic's first year compared with the year before.
  Medscape Medical News, June 29, 2022
• Disturbed Sleep Drives Poor PrEP Adherence Sleep may be the missing link in poor PrEP adherence, according to study findings.
  Medscape Medical News, June 16, 2022
• Primary Care Doc Education May Increase PrEP Prescribing Educating primary care clinicians about preexposure prophylaxis for HIV could help ease the shortage in clinicians who prescribe the drugs, a study found.
  Medscape Medical News, June 15, 2022
• TDF Use in HBV-HIV Coinfection Linked With Kidney, Bone Issues Kidney function and bone turnover may worsen in patients who are coinfected with HBV and HIV and take tenofovir disoproxil fumarate (TDF), researchers report.
  Medscape Medical News, June 01, 2022
• With COVID, 2020 Was 'Lost Year' in Fight Against HIV Due to the COVID-19 pandemic, 2020 was likely a "lost year" in the public health battle against the long-lasting HIV epidemic in the US, a public health official says.
  WebMD Health News, May 25, 2022
• DDW 2022 PI–Based DAAs Appear Safe in Decompensated Patients 974504
  Medscape Medical News, May 24, 2022
• Vitamins, OTC Drugs May Interact With HIV Antiretroviral Therapy OTC medications, food supplements, and other drugs may interact with antiretroviral therapy and harm people living with HIV, researchers in Denmark report.
  Medscape Medical News, May 20, 2022
• Gilead Settles With Defendants in HIV PrEP Fraud Lawsuit Gilead settled its lawsuit alleging a $68 million scheme took advantage of its program to supply free HIV prevention drugs.
  Medscape Medical News, May 16, 2022
• Support for Gilead Drug's Benefit Against Multidrug-Resistant HIV Lenacapavir produces higher levels of viral suppression after 26 weeks among patients with multidrug-resistant disease when given in addition to other antiretrovirals, according to results from the CAPELLA trial.
  Reuters Health Information, May 11, 2022
• ATS 2022 ATS 2022: Restoration in the Aftermath of COVID-19 Lessons learned from the pandemic will be a central theme of this year's meeting, held live for the first time since 2019.
  Medscape Medical News, May 10, 2022
• Decentralizing PrEP Offers a Roadmap for Retention University of Washington researchers tested a de-medicalized PrEP model at a sexual health clinic to increase PrEP initiation and retention.
  Medscape Medical News, May 10, 2022